Vertex Inc. (VERX)
NASDAQ: VERX
· Real-Time Price · USD
24.26
-0.47 (-1.90%)
At close: Oct 14, 2025, 9:38 AM
-1.90% (1D)
| Bid | 24.25 |
| Market Cap | 3.87B |
| Revenue (ttm) | 710.51M |
| Net Income (ttm) | -50.41M |
| EPS (ttm) | -0.33 |
| PE Ratio (ttm) | -73.52 |
| Forward PE | 32.61 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 24.34 |
| Volume | 25,350 |
| Avg. Volume (20D) | 1,524,668 |
| Open | 24.47 |
| Previous Close | 24.73 |
| Day's Range | 24.23 - 24.56 |
| 52-Week Range | 23.13 - 60.71 |
| Beta | 0.63 |
| Ex-Dividend Date | n/a |
About VERX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VERX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VERX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsVertex Inc. is scheduled to release its earnings on
Nov 3, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-18.05%
Vertex shares are trading lower after the company ...
Unlock content with
Pro Subscription
5 months ago
+0.21%
VERX stock has given up its prior gain. Vertex shares were trading higher after the company reported better-than-expected Q1 financial results.
2 weeks ago · seekingalpha.com
Vertex Pharmaceuticals: Trikafta And Alyftrek Cement Market LeadershipEven amid political pressure from RFK Jr. and President Trump, as well as failed clinical data on VX-993, Vertex continues to strengthen its position in the cystic fibrosis market. Sales of its three ...
